{
    "clinical_study": {
        "@rank": "36665", 
        "biospec_descr": {
            "textblock": "A baseline CSF sample will be obtained prior to intrathecal chemotherapy. CSF biomarkers\n      will be obtained at the initiation of post-induction, 4 and 6 months into post-induction\n      therapy, and at the start of maintenance therapy.A saliva sample will be obtained for\n      genotypic analysis at one of the four data collection times."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the phenotypic and genotypic characteristics and\n      their associations with symptom clusters experienced during treatment for childhood\n      leukemia."
        }, 
        "brief_title": "Symptom Clusters in Children With Leukemia", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Childhood Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "A repeated measures research design will evaluate phenotypic and genotypic treatment-related\n      symptom associations experienced by children and adolescents 3-17 years of age with a\n      diagnosis of leukemia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Phenotypic and genotypic treatment-related symptom associations will be evaluated in\n             children and adolescents 3-18 years of age with a diagnosis of leukemia.\n\n        Exclusion Criteria:\n\n          -  Children without a definite diagnosis of leukemia will be excluded.\n\n          -  Children must be able to understand and answer the questions on the questionnaires.\n\n          -  Children with have a cognitive impairment (e.g. Down syndrome) will not be able to\n             complete the questionnaires and will not be eligible for the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "3 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Children between 3-18 years of age undergoing treatment for leukemia."
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708421", 
            "org_study_id": "Pro00037891"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "contact": {
                "last_name": "Marilyn Hockenberry, PhD", 
                "phone": "919-684-9330"
            }, 
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University Medical Center"
            }, 
            "investigator": {
                "last_name": "Sharron Docherty, PhD,CPNP", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment", 
        "overall_contact": {
            "email": "marilyn.hockenberry@duke.edu", 
            "last_name": "Marilyn Hockenberry, PhD", 
            "phone": "919-684-9330"
        }, 
        "overall_official": {
            "affiliation": "Duke University School of Nursing", 
            "last_name": "Marilyn Hockenberyy, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708421"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}